ANPEP and type 2 diabetes mellitus: Plasma APN levels can also be upregulated by thiazolidinediones (TZDs), such as pioglitazone, rosiglitazone, a class of PPAR-γ agonists and medicine used in the treatment of type II diabetes (T2D).